Hemisphere GNSS Introduces GradeMetrix® Scraper
October 25, 2022 09:00 ET
|
Hemisphere GNSS (989444)
MUNICH, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Hemisphere GNSS, Inc. announces the release of the GradeMetrix® Scraper Solution for pull pan and belly pan scrapers. "We believe by introducing...
Revolution Medicines Strengthens Senior Management Team with Promotions and a New Hire
September 01, 2022 16:05 ET
|
Revolution Medicines, Inc.
Company Promotes Jack Anders to Chief Financial Officer and Jeff Cislini to General Counsel Daniel Simon to Join Company as Chief Business Officer REDWOOD CITY, Calif., Sept. 01, 2022 (GLOBE...
Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
July 22, 2022 16:02 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., July 22, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Revolution Medicines Announces Pricing of Upsized $230.0 Million Public Offering of Common Stock
July 19, 2022 22:41 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Revolution Medicines Announces Commencement of Public Offering of Common Stock
July 19, 2022 16:01 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Revolution Medicines Advances First RAS(ON) Inhibitor into Clinic, Dosing First Patient in Phase 1/1b Trial of RMC-6236
June 28, 2022 07:00 ET
|
Revolution Medicines, Inc.
First-in-class, oral, RAS(ON) Inhibitor being evaluated initially in patients with cancers driven by KRASG12 mutations Sushil Patel, Ph.D., industry veteran with commercial oncology expertise,...
EarthScout Launches New Mini Wireless Soil Cub Field Sensor
April 12, 2022 08:30 ET
|
EarthScout
MINNEAPOLIS, April 12, 2022 (GLOBE NEWSWIRE) -- Agtech company EarthScout today announced a new addition to its scalable line of agriculture smart products that help farmers and food producers...
Piezo Motion’s Precise Motor Technology Is Now Available in Germany
March 24, 2022 08:00 ET
|
Brain Scientific Inc.
LAKEWOOD RANCH, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, and MEV Elektronik Service GmbH, a manufacturing representative...
Revolution Medicines Announces Seven Oral Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2022
March 09, 2022 07:30 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corporate Progress
February 28, 2022 16:05 ET
|
Revolution Medicines, Inc.
RAS(ON) Inhibitor Pipeline Continues to Advance and Expand, Now Addressing Majority of RAS-Addicted Cancers; Two New Drug Candidates Recently Nominated Recently Announced First Patient Dosed in...